TY - JOUR
T1 - Implementation of digital home monitoring of respiratory disease and management
AU - Pinnock, Hilary
AU - Hui, Chi yan
AU - van Boven, Job F.M.
N1 - Funding Information:
J.F.M.v.B. received grants and/or consultancy fees from AstraZeneca, Chiesi, European Commission COST (COST Action 19132 ‘ENABLE’), GSK, Novartis, Pfizer, Teva and Trudell Medical, outside the submitted work and all paid to his institution. C.y.H. is a visitor in the University of Edinburgh and is a senior consultant in digital health at Deloitte. Her research with the University of Edinburgh, is independent from, and not financially supported by Deloitte. Her views in this publication are her own, and not those of the Deloitte. Neither she, nor Deloitte, stand to gain financially from this work.
Funding Information:
H.P. has received speaker fees from Teva and Sandoz outside the submitted work. She holds, or has recently held research grants within the University of Edinburgh from the National Institute for Health and Care Research, Asthma and Lung UK, Innovate UK.
Publisher Copyright:
© 2023 Lippincott Williams and Wilkins. All rights reserved.
PY - 2023/7/1
Y1 - 2023/7/1
N2 - PURPOSE OF REVIEW: Digital respiratory monitoring interventions (e.g. smart inhalers and digital spirometers) can improve clinical outcomes and/or organizational efficiency, and the focus is shifting to sustainable implementation as an approach to delivering respiratory care. This review considers key aspects of the technology infrastructure, discusses the regulatory, financial and policy context that influence implementation, and highlights the over-arching societal themes of equity, trust and communication.RECENT FINDINGS: Technological requirements include developing interoperable and connected systems; establishing stable, wide internet coverage; addressing data accuracy and monitoring adherence; realising the potential of artificial intelligence; and avoiding clinician data overload. Policy challenges include concerns about quality assurance and increasingly complex regulatory systems. Financial barriers include lack of clarity over cost-effectiveness, budget impact and reimbursement. Societal concerns focus on the potential to increase inequities because of poor e-health literacy, deprivation or lack of available infrastructure, the need to understand the implications for patient/professional interactions of shifting care to remote delivery and ensuring confidentiality of personal data.SUMMARY: Understanding and addressing the implementation challenges posed by gaps in policy, regulatory, financial, and technical infrastructure is essential to support delivery of equitable respiratory care that is acceptable to patients and professionals.
AB - PURPOSE OF REVIEW: Digital respiratory monitoring interventions (e.g. smart inhalers and digital spirometers) can improve clinical outcomes and/or organizational efficiency, and the focus is shifting to sustainable implementation as an approach to delivering respiratory care. This review considers key aspects of the technology infrastructure, discusses the regulatory, financial and policy context that influence implementation, and highlights the over-arching societal themes of equity, trust and communication.RECENT FINDINGS: Technological requirements include developing interoperable and connected systems; establishing stable, wide internet coverage; addressing data accuracy and monitoring adherence; realising the potential of artificial intelligence; and avoiding clinician data overload. Policy challenges include concerns about quality assurance and increasingly complex regulatory systems. Financial barriers include lack of clarity over cost-effectiveness, budget impact and reimbursement. Societal concerns focus on the potential to increase inequities because of poor e-health literacy, deprivation or lack of available infrastructure, the need to understand the implications for patient/professional interactions of shifting care to remote delivery and ensuring confidentiality of personal data.SUMMARY: Understanding and addressing the implementation challenges posed by gaps in policy, regulatory, financial, and technical infrastructure is essential to support delivery of equitable respiratory care that is acceptable to patients and professionals.
KW - Artificial Intelligence
KW - Communication
KW - Humans
KW - Respiratory Tract Diseases
U2 - 10.1097/MCP.0000000000000965
DO - 10.1097/MCP.0000000000000965
M3 - Article
C2 - 37132298
SN - 1070-5287
VL - 29
SP - 302
EP - 312
JO - Current opinion in pulmonary medicine
JF - Current opinion in pulmonary medicine
IS - 4
ER -